Cargando…

Efficacy and Safety of Escitalopram Oral Drops to Treat Major Depressive Disorder and Generalized Anxiety Disorder in Adolescent, Adult and Geriatric Patients: A Prospective Multicenter Observational Study in Pakistan

Background Escitalopram is widely used for the management of the major depressive disorder and generalized anxiety disorder, but there is no to very limited data available regarding efficacy and safety in Pakistani patients. This study was conducted to evaluate the efficacy and safety of escitalopr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Afridi, Muhammad Iqbal, Dogar, Imtiaz Ahmad, Nizami, Asad T, Aslam, Rubina, Mustafa, Ali Burhan, Syed Muhammad, Sharib, Maheshwary, Neeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046010/ https://www.ncbi.nlm.nih.gov/pubmed/32140351 http://dx.doi.org/10.7759/cureus.6792

Ejemplares similares

Clinical Efficacy and Safety of Injectable Levetiracetam Versus Phenytoin as Second-Line Therapy in the Management of Generalized Convulsive Status Epilepticus in Children: An Open-Label Randomized Controlled Trial
por: Noureen, Nuzhat, et al.
Publicado: (2019)

Regional White Matter Integrity Predicts Treatment Response to Escitalopram and Memantine in Geriatric Depression: A Pilot Study
por: Krause-Sorio, Beatrix, et al.
Publicado: (2020)

An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
por: Santi, N Simple, et al.
Publicado: (2023)

Efficacy and Safety of Sofosbuvir-Velpatasvir combination in Hepatitis C Virus-infected Pakistani Patients without Cirrhosis or with Compensated Cirrhosis: A Prospective, Open-label Interventional Trial
por: Butt, Nazish, et al.
Publicado: (2020)

Knowledge and Response to the COVID-19 Pandemic in People With Severe Mental Illness in Bangladesh and Pakistan: A Cross-Sectional Survey
por: Rajan, Sukanya, et al.
Publicado: (2022)

Development and Internal Validation of a Novel Model to Identify Inflammatory Biomarkers of a Response to Escitalopram in Patients With Major Depressive Disorder
por: Zhou, Jingjing, et al.
Publicado: (2021)

Forensic psychiatric service provision in Pakistan and its challenges
por: Hassan, Tariq, et al.
Publicado: (2017)

A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine
por: Li, Zhe, et al.
Publicado: (2023)

Prevalence of neuropsychiatric disorders in patients with systemic lupus erythematosus in Pakistan: A systematic review and meta-analysis
por: Khan, Muhammad Imran, et al.
Publicado: (2023)

A Case Study of Depression in High Achieving Students Associated With Moral Incongruence, Spiritual Distress, and Feelings of Guilt
por: Najeeb, Bahjat, et al.
Publicado: (2023)

Label-Free Liquid Chromatography–Mass Spectrometry Proteomic Analysis of the Urinary Proteome for Measuring the Escitalopram Treatment Response From Major Depressive Disorder
por: Huan, Yuhang, et al.
Publicado: (2021)

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder
por: François, C, et al.
Publicado: (2008)

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram
por: Toshida, Masamitsu, et al.
Publicado: (2021)

Differential Effects of Single-Dose Escitalopram on Cognitive and Affective Interference during Stroop Task
por: Rahm, Christoffer, et al.
Publicado: (2014)

Cerebrospinal fluid cytokines in geriatric patients with depressive disorders: A retrospective case-control study
por: Schou, Morten Brix, et al.
Publicado: (2022)

The Impact of COVID-19 on the Psychological Well-Being of Surgeons in Pakistan: A Multicenter Cross-Sectional Study
por: Zeeshan, Sana, et al.
Publicado: (2022)

Study protocol of DIVERGE, the first genetic epidemiological study of major depressive disorder in Pakistan
por: Valkovskaya, Maria, et al.
Publicado: (2023)

Resistant social anxiety disorder response to Escitalopram
por: Pallanti, Stefano, et al.
Publicado: (2006)

The therapeutic potential of escitalopram in the treatment of panic disorder
por: Townsend, Mark H, et al.
Publicado: (2007)

Terrorism in Pakistan: the psychosocial context and why it matters
por: Nizami, Asad Tamizuddin, et al.
Publicado: (2018)

Cardiovascular adverse reactions associated with escitalopram in patients with underlying cardiovascular diseases: a systematic review and meta-analysis
por: Kimura, Kenichi, et al.
Publicado: (2023)

Implementation of an infant male circumcision programme, Pakistan
por: Moosa, Shazia, et al.
Publicado: (2021)

Metoprolol, N-Acetylcysteine, and Escitalopram Prevents Chronic Unpredictable Mild Stress-Induced Depression by Inhibition of Endoplasmic Reticulum Stress
por: Yang, Lixia, et al.
Publicado: (2018)

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy
por: Eichentopf, Luzie, et al.
Publicado: (2022)

An emerging role for escitalopram in the treatment of obsessive-compulsive disorder
por: Hedges, Dawson W, et al.
Publicado: (2007)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Ali, Mazen K, et al.
Publicado: (2011)

Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders
por: Alkhowaiter, Saad S., et al.
Publicado: (2023)

The association of symptoms of dhat syndrome with comorbid obsessive-compulsive disorder: A case report
por: Malik, Muhammad Faisal Amir, et al.
Publicado: (2023)

A Case of Pediatric Post-Traumatic Stress Disorder Presenting as Attention Deficit Hyperactivity Disorder: A Case Report
por: Tahir, Muhammad A, et al.
Publicado: (2017)

Prevalence of Migraine among patients of Depressive Disorder
por: Jat, Muhammad Ilyas, et al.
Publicado: (2018)

Consequences of traffic noise in residents of Karachi, Pakistan
por: Siddiqui, Imtiaz Ather, et al.
Publicado: (2015)

Psychiatric Morbidity, Perceived Stress and Ways of Coping Among Parents of Children With Intellectual Disability in Lahore, Pakistan
por: Sheikh, Muhammad H, et al.
Publicado: (2018)

Cultural Adaptation and Validation of the Urdu Version of the Cognitive Emotion Regulation Questionnaire (CERQ) in Male Patients With Substance Use Disorders (SUDs) in Pakistan
por: Shahzad, Salman, et al.
Publicado: (2022)

Shared Psychotic Disorder (Folie À Deux): A Rare Case with Dissociative Trance Disorder That Can Be Induced
por: Saragih, Munawir, et al.
Publicado: (2019)

Mild cognitive disorder and depression: treatment with combination of galantamine and escitalopram
por: Zarra, Julio, et al.
Publicado: (2010)

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
por: Mencacci, Claudio, et al.
Publicado: (2013)

Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial
por: Cigognini, Marco Aurélio, et al.
Publicado: (2022)

Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report
por: Wu, Jianhong, et al.
Publicado: (2023)

Behavioral, cortical and autonomic effects of single-dose escitalopram on the induction and regulation of fear and disgust: Comparison with single-session psychological emotion regulation with reappraisal
por: Sklivanioti Greenfield, Myrto, et al.
Publicado: (2023)

Role of Oxytocin in the Pathogenesis and Modulation of Borderline Personality Disorder: A Review
por: Jawad, Muhammad Youshay, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fuf7iq4m36862fsr1sibsuv51h